This social network is a secure place for Epilepsy education, discussion, and blogging! You will find courses, videos, a growing network of real, supportive, members and much more! Make friends and view content like this great webinar inside! Sign-up here »
18 September, 2012
Published by EpilepsyUni in Epilepsy, Medicine, Neurology, News, Treatment
New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in [...]
29 March, 2012
Published by EpilepsyUni in Epilepsy, Medicine, Neurology, Treatment
BALTIMORE – A Severn couple dealing with their daughter’s severe epilepsy said a new diet that’s high in fat has changed their 7-year-old’s life. Nadiya Pelovitz was diagnosed at 13 months with lynex gesteaux syndrome, which is a severe form of epilepsy that, in addition to seizures, has dramatically affected her development. Nadiya’s parents said she [...]
13 March, 2012
Published by EpilepsyUni in Epilepsy, Family and Friends, Local, Medicine, Neurology, News, Seizures, Technology, Treatment, VNS, Women and Epilepsy
This is a fantastic story about VNS therapy success for one of our friends, Tina Lewis. A woman who live in Paradise, CA has found a way to control her seizures and she wants to get the word out. After a snowmobile accident in Butte Meadows in 2002, Tina Lewis, 45, began suffering epileptic seizures [...]
15 February, 2012
Published by EpilepsyUni in Epilepsy, Medicine, News
British scientists have successfully generated brain tissue from human skin. The team has for the first time generated a crucial type of brain cells in the laboratory by reprogramming skin cells. They say it could speed up the hunt for new treatments for conditions such as Alzheimer’s disease, epilepsy and stroke. Until now it has only been possible to generate tissue [...]
6 February, 2012
Published by EpilepsyUni in Epilepsy, Medicine, Technology
To explore the most intricate structures of the brain in order to decipher how it functions – Stefan Hell’s team of researchers at the Max Planck Institute for Biophysical Chemistry in Göttingen has made a significant step closer to this goal. Using the STED microscopy developed by Hell, the scientists have, for the first time, managed to [...]
29 August, 2011
Published by ceil Layfield in Epilepsy, Local, Medicine, News
Eisai and BIAL announced today that 25 abstracts, highlighting an extensive development programme for Zebinix® (eslicarbazepine acetate), have been accepted for presentation during the 29th International Epilepsy Congress, taking place in Rome from 28 August until 1 September, 2011. The presentations evaluate the use of eslicarbazepine acetate as monotherapy, its efficacy and safety in children [...]
29 June, 2011
Published by EpilepsyUni in Epilepsy, News
One of the most commonly prescribed antiepileptic drugs is phenytoin, otherwise known as the brand name of Dilantin®. This medication which was discovered in 1938 was found to be one of the earliest agents with a potential to stop seizures, yet without causing sedation. As a result and because there were very few drugs in [...]
21 June, 2011
Published by EpilepsyUni in Epilepsy, Global, Medicine, News
Dr. Larry Hirsch and other investigators published a report of the National Institutes of Health Workshop on Sudden Unexpected Death in Epilepsy (SUDEP) in the May 31, 2011, issue of the journal Neurology. The report summarizes the discussions and recommendations of the workgroup including lessons learned from investigations of sudden infant death syndrome, sudden cardiac [...]
GlaxoSmithKline has today launched Trobalt® (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with partial-onset seizures, and demonstrated significant effects in a treatment resistant patient population.1 Retigabine is the first and currently only AED to target neuronal potassium channels1 which are involved in inhibitory mechanisms in [...]
Recent Comments